Individual Lymphocyte Sensitivity to Steroids as a Reliable Biomarker for Clinical Outcome after Steroid Withdrawal in Japanese Renal Transplantation

Recently, steroid reduction/withdrawal regimens have been attempted to minimize the side effects of steroids in renal transplantation. However, some recipients have experienced an increase/resumption of steroid administrations and acute graft rejection (AR). Therefore, we investigated the relationship between the individual lymphocyte sensitivity to steroids and the clinical outcome after steroid reduction/withdrawal. We cultured peripheral blood mononuclear cells (PBMCs) isolated from 24 recipients with concanavalin A (Con A) in the presence of methylprednisolone (MPSL) or cortisol (COR) for four days, and the 50% of PBMC proliferation (IC50) values and the PBMC sensitivity to steroids were calculated. Regarding the experience of steroid increase/resumption and incidence of AR within one year of steroid reduction/withdrawal, the IC50 values of these drugs before transplantation in the clinical event group were significantly higher than those in the event-free group. The cumulative incidence of steroid increase/resumption and AR in the PBMC high-sensitivity groups to these drugs before transplantation were significantly lower than those in the low-sensitivity groups. These observations suggested that an individual’s lymphocyte sensitivity to steroids could be a reliable biomarker to predict the clinical outcome after steroid reduction/withdrawal and to select the patients whose dose of steroids can be decreased and/or withdrawn after transplantation.

[1]  N. Aslam,et al.  Prospective nonrandomized study with early steroid withdrawal (Day 5) postrenal transplant in low immunological risk patients: A singlecenter experience at prince sultan military medical city Riyadh , 2019, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[2]  K. Woodside,et al.  Racial disparity in kidney transplant survival relates to late rejection and is independent of steroid withdrawal , 2018, Clinical transplantation.

[3]  Neetika Garg,et al.  Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid‐withdrawal regimens: a retrospective analysis of the UNOS/OPTN database , 2018, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  A. Matas,et al.  Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes From the University of Minnesota , 2017, Transplantation.

[5]  D. Conti,et al.  Early steroid withdrawal results in improved patient and graft survival and lower risk of post‐transplant cardiovascular risk profiles: A single‐center 10‐year experience , 2017, Clinical transplantation.

[6]  G. Heinze,et al.  Steroid withdrawal after renal transplantation: a retrospective cohort study , 2017, BMC Medicine.

[7]  K. Hunt,et al.  A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[8]  A. Webster,et al.  Steroid avoidance or withdrawal for kidney transplant recipients. , 2016, The Cochrane database of systematic reviews.

[9]  A. Matas,et al.  Prospective Randomized Trial of Maintenance Immunosuppression With Rapid Discontinuation of Prednisone in Adult Kidney Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  A. Matas,et al.  Recurrent Glomerulonephritis Under Rapid Discontinuation of Steroids , 2011, Transplantation.

[11]  D. Hricik,et al.  Influence of African-American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients. , 2010, Transplantation proceedings.

[12]  E. Woodle,et al.  A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy , 2008, Annals of surgery.

[13]  D. Hricik,et al.  Long-Term Graft Outcomes After Steroid Withdrawal in African American Kidney Transplant Recipients Receiving Sirolimus and Tacrolimus , 2007, Transplantation.

[14]  J. Pascual,et al.  Steroid Withdrawal in Renal Transplant Patients on Triple Therapy with a Calcineurin Inhibitor and Mycophenolate Mofetil: A Meta-analysis of Randomized, Controlled Trials , 2004, Transplantation.

[15]  S. Takahara,et al.  Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients. , 2001, Transplantation proceedings.

[16]  K. Oka,et al.  A comparison of prednisolone and methylprednisolone for renal transplantation , 2000, Clinical transplantation.

[17]  J Hornberger,et al.  Incidence and long-term cost of steroid-related side effects after renal transplantation. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  A. Steinberg,et al.  The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry. , 1994, Transplantation.

[19]  P. Kimball,et al.  Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. , 1991, Transplantation.

[20]  A. Cueto-Manzano,et al.  Early Steroid Withdrawal in Recipients of a Kidney Transplant From a Living Donor: Experience of a Single Mexican Center. , 2016, Transplantation proceedings.